Effect of Immediate Antihypertensive Treatment on Clinical Outcomes in Acute Ischemic Stroke Patients With Different

Yujia Zhai1, Bizhong Che1, Yang Liu2,3

  • 1Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, China (Y.Z., B.C., H.P., A.W., Y.Z., T.X., C.Z.).

Insights

Early blood pressure management in acute ischemic stroke patients showed no significant difference in outcomes, regardless of kidney function. This study analyzed data from the CATIS trial, finding a neutral effect across different estimated glomerular filtration rate (eGFR) levels.

Area of Science:

  • Neurology
  • Nephrology
  • Cardiology

Background:

  • Optimal blood pressure management in acute stroke patients with varying renal function remains unclear.
  • The China Antihypertensive Trial in Acute Ischemic Stroke (CATIS) investigated this question.

Purpose of the Study:

  • To analyze the effect of early antihypertensive treatment on acute ischemic stroke patients based on baseline renal function.
  • To stratify outcomes by estimated glomerular filtration rates (eGFR).

Main Methods:

  • Secondary analysis of the CATIS trial involving 4071 acute ischemic stroke patients.
  • Patients were assigned to antihypertensive treatment or control (discontinue medication).
  • Outcomes were compared across eGFR groups: <60, 60-89, and ≥90 mL/min per 1.73 m².

Main Results:

  • No significant difference in the primary outcome (death or major disability) between treatment and control groups across all eGFR strata (P=0.98 for homogeneity).
  • Odds ratios for the primary outcome were 1.23 (<60 eGFR), 0.94 (60-89 eGFR), and 1.04 (≥90 eGFR).
  • Early antihypertensive treatment showed no association with secondary clinical outcomes based on renal function.

Conclusions:

  • Early antihypertensive treatment demonstrated a neutral effect on clinical outcomes in ischemic stroke patients.
  • Renal function status did not alter the impact of early antihypertensive treatment on stroke outcomes.
Abstract

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
757
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
485
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
141
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
40
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
46